Table 2.

Best overall response and outcome for patients who discontinued ICI treatment

Best overall Response	Number of patients	Patients diagnosed with PD	Mean time of anti-PD-1 treatment	Mean time of response durability after discontinuation
	N (%)	N (%)	months (range)	months (range)
Complete response	6 (30%)	2 (33%)	9.3 months (range 3–27)	11.5 months (1–20)
Partial response	11 (55%)	7 (66%)	10.4 months (range 5–16)	11.2 months (range 1–24)
Stable disease	3 (15%)	3 (100%)	10 months (range 6–12)	7 months (range 5–10)

ICI, immune checkpoint inhibitors; PD, progressive disease; PD-1, programmed cell death protein 1